Microbiota and gut neuropeptides: a dual action of antimicrobial activity and neuroimmune response

被引:0
|
作者
Julia Aresti Sanz
Sahar El Aidy
机构
[1] University of Groningen,Department of Molecular Immunology and Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute (GBB)
来源
Psychopharmacology | 2019年 / 236卷
关键词
Neuropeptides; Bacteria; Neuro-immune response; Gut-brain axis;
D O I
暂无
中图分类号
学科分类号
摘要
The gut microbiota is comprised of a vast variety of microbes that colonize the gastrointestinal tract and exert crucial roles for the host health. These microorganisms, partially via their breakdown of dietary components, are able to modulate immune response, mood, and behavior, establishing a chemical dialogue in the microbiota–gut–brain interphase. Changes in the gut microbiota composition and functionality are associated with multiple diseases, in which altered levels of gut-associated neuropeptides are also detected. Gut neuropeptides are strong neuroimmune modulators; they mediate the communication between the gut microbiota and the host (including gut–brain axis) and have also recently been found to exert antimicrobial properties. This highlights the importance of understanding the interplay between gut neuropeptides and microbiota and their implications on host health. Here, we will discuss how gut neuropeptides help to maintain a balanced microbiota and we will point at the missing gaps that need to be further investigated in order to elucidate whether these molecules are related to neuropsychiatric disorders, which are often associated with gut dysbiosis and altered gut neuropeptide levels.
引用
收藏
页码:1597 / 1609
页数:12
相关论文
共 50 条
  • [21] Review article: the antimicrobial effects of rifaximin on the gut microbiota
    DuPont, H. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 : 3 - 10
  • [22] The Role of Gut Microbiota in Drug Response
    Wilson, I. D.
    Nicholson, J. K.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (13) : 1519 - 1523
  • [23] Gliadin peptidase activity of gut microbiota
    Olivares, M.
    Lopez, A.
    Laparra, J.
    Sanz, Y.
    ANNALS OF NUTRITION AND METABOLISM, 2011, 58 : 75 - 75
  • [24] Gut microbiota response to antibiotics is personalized and depends on baseline microbiota
    Rashidi, Armin
    Ebadi, Maryam
    Rehman, Tauseef Ur
    Elhusseini, Heba
    Nalluri, Harika
    Kaiser, Thomas
    Holtan, Shernan G.
    Khoruts, Alexander
    Weisdorf, Daniel J.
    Staley, Christopher
    MICROBIOME, 2021, 9 (01)
  • [25] Gut microbiota response to antibiotics is personalized and depends on baseline microbiota
    Armin Rashidi
    Maryam Ebadi
    Tauseef Ur Rehman
    Heba Elhusseini
    Harika Nalluri
    Thomas Kaiser
    Shernan G. Holtan
    Alexander Khoruts
    Daniel J. Weisdorf
    Christopher Staley
    Microbiome, 9
  • [26] In silico prediction reveals the existence of potential bioactive neuropeptides produced by the human gut microbiota
    Blanco-Miguez, Aitor
    Fdez-Riverola, Florentino
    Lourenco, Anglia
    Sanchez, Borja
    FOOD RESEARCH INTERNATIONAL, 2019, 119 : 221 - 226
  • [27] Crosstalk between gut microbiota and antidiabetic drug action
    Kyriachenko, Yevheniia
    Falalyeyeva, Tetyana
    Korotkyi, Oleksandr
    Molochek, Nataliia
    Kobyliak, Nazarii
    WORLD JOURNAL OF DIABETES, 2019, 10 (03) : 154 - 168
  • [28] The gut microbiota profile is associated with insulin action in humans
    Serino, Matteo
    Manuel Fernandez-Real, Jose
    Fuentes, Eduardo Garcia
    Queipo-Ortuno, Maribel
    Maria Moreno-Navarrete, Jose
    Sanchez, Alex
    Burcelin, Remy
    Tinahones, Francisco
    ACTA DIABETOLOGICA, 2013, 50 (05) : 753 - 761
  • [29] Gut Microbiota and Breast Cancer: The Dual Role of Microbes
    Alvarez-Mercado, Ana Isabel
    del Valle Cano, Ana
    Fernandez, Mariana F. F.
    Fontana, Luis
    CANCERS, 2023, 15 (02)
  • [30] The gut microbiota profile is associated with insulin action in humans
    Matteo Serino
    José Manuel Fernández-Real
    Eduardo García Fuentes
    Maribel Queipo-Ortuño
    José María Moreno-Navarrete
    Álex Sánchez
    Rémy Burcelin
    Francisco Tinahones
    Acta Diabetologica, 2013, 50 : 753 - 761